Publication | Open Access
SCG2: A Prognostic Marker That Pinpoints Chemotherapy and Immunotherapy in Colorectal Cancer
21
Citations
23
References
2022
Year
This study demonstrates the clinical significance and biological characteristics of SCG2, which could serve as a promising biomarker to identify patients who may benefit from chemotherapy and immunotherapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1